Stockreport

Aura Stock Up as Lead Drug Shows Superior Efficacy in Eye Cancer Study [Yahoo! Finance]

Aura Biosciences, Inc.  (AURA) 
PDF Shares of Aura Biosciences AURA gained 7.9% on Sept. 12 after the company announced encouraging data from a phase II study evaluating its lead candidate, bel-sar (AU-01 [Read more]